DE915853C - Process for the manufacture of vaccines - Google Patents
Process for the manufacture of vaccinesInfo
- Publication number
- DE915853C DE915853C DES11800D DES0011800D DE915853C DE 915853 C DE915853 C DE 915853C DE S11800 D DES11800 D DE S11800D DE S0011800 D DES0011800 D DE S0011800D DE 915853 C DE915853 C DE 915853C
- Authority
- DE
- Germany
- Prior art keywords
- vaccines
- virus
- immunization
- manufacture
- sound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
- A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/00051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Description
Verfahren zur Herstellung von Impfstoffen Die Erfindung betrifft ein Verfahren zur Herstellung von Impfstoffen zur aktiven Immunisierung, insbesondere gegen Viruskrankheiten. Erfindungsgemäß werden die Bakterien, insbesondere Virus, der krank machenden Wirkung durch Schall, insbesondere Ultraschall, beraubt. Dabei wird die Beschallung so gesteuert, daß die Vermehrungsfähigkeit des Krankheitserregers zerstört wird, daß aber die den Immunisierungsvorgang bedingenden chemischen Gruppen erhalten bleiben.Process for making vaccines The invention relates to a Process for the preparation of vaccines for active immunization, in particular against viral diseases. According to the invention, the bacteria, in particular virus, deprived of the pathogenic effects of sound, especially ultrasound. Included the sound is controlled so that the ability of the pathogen to multiply is destroyed, but that the chemical groups causing the immunization process remain.
Man kann das Verfahren nach der Erfindung zur Herstellung von Impfstoffen für die Impfung von Mensch und Tier bei Infektionskrankheiten, die eine natürliche Immunität hinterlassen, anwenden. Bei Versuchen mit Tabakmosaikvirus wurde festgestellt, daß Ultraschall die krank machende Wirkung des Virusproteins aufhebt.Die elektronenmikroskopische Untersuchung beschallter Viruslösungen zeigte, daß die Virusmoleküle zerschlagen sind. Wahrscheinlich ist diese Zerschlagung für den Verlust der Vermehrungsfähigkeit des Virus verantwortlich. Die Virusbruchstücke können erfindungsgemäß zur Immunisierung verwendet werden. Auf diesem Gedanken aufbauend, können bei Anwendung der Erfindung u. a. Impfstoffe für Maul- und Klauenseuche hergestellt werden. One can use the method of the invention for the preparation of vaccines for vaccination of humans and animals in infectious diseases that are a natural Leave immunity, apply. Tests with tobacco mosaic virus found that ultrasound cancels the disease-causing effect of the virus protein Examination of sonicated virus solutions showed that the virus molecules disintegrated are. Probably this breaking up is for the loss of the ability to reproduce of the virus. According to the invention, the virus fragments can be used for immunization be used. Building on this idea, when applying the invention i.a. Vaccines for foot and mouth disease are made.
Das neue Verfahren vermeidet jeden Zusatz von Fremdstoffen (Phenol, Adsorbentien u. dgl.) und erhöht durch Verritigerung des zur I mpfung erforderlichen Impfstoffvolumens die Leistungsfähigkeit der Impfstoffproduktionsstellen. The new process avoids any addition of foreign substances (phenol, Adsorbents and the like) and increased by denial of the vaccination the vaccine production facilities.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DES11800D DE915853C (en) | 1945-02-01 | 1945-02-01 | Process for the manufacture of vaccines |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DES11800D DE915853C (en) | 1945-02-01 | 1945-02-01 | Process for the manufacture of vaccines |
Publications (1)
Publication Number | Publication Date |
---|---|
DE915853C true DE915853C (en) | 1954-07-29 |
Family
ID=7473769
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DES11800D Expired DE915853C (en) | 1945-02-01 | 1945-02-01 | Process for the manufacture of vaccines |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE915853C (en) |
-
1945
- 1945-02-01 DE DES11800D patent/DE915853C/en not_active Expired
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AT408615B (en) | NEW INFLUENCE VIRUS VACCINE COMPOSITION | |
WO1989007946A1 (en) | Virally modified tumour vaccines for immunotherapy of tumour metastases | |
DE1220969B (en) | Process for improving structurally damaged hair | |
DE915853C (en) | Process for the manufacture of vaccines | |
DE2323847C3 (en) | Live vaccine for the immunization of cattle against parainfluenza 3 virus infection | |
DE1924304B2 (en) | Diethylaminoethyldextran (DEAE-D) as an adjuvant for vaccines for the active immunization of mammals | |
DE539018C (en) | Process for the production of locally immunizing substances from bacteria (staphylococci, streptococci, bacterium coli) | |
DE4141970C2 (en) | Combination vaccine against AIDS, schistosomiasis and tuberculosis and process for its preparation | |
DE753154C (en) | Process for the production of a dry preparation from blood or serum for therapeutic purposes | |
DE1021133B (en) | Process for the manufacture of vaccines against viral diseases | |
DE4122906A1 (en) | Divested bacteria prepn. for vaccines - by binding partially oxidised polysaccharide to surface, and coating modified bacteria with viral or bacterial protein or polypeptide | |
DE4236069A1 (en) | Homeopathic medicaments for treating HIV infections - prepd. by dilution of infected serum | |
GB953992A (en) | Vaccine products and method of preparing same | |
DE384635C (en) | Process for the preparation of vaccines from human tuberculosis bacilli or bovine tubercle bacilli for protection against tuberculosis | |
DE672415C (en) | Process for the preparation of vaccines against bogus burn in animals | |
DE102020108453A1 (en) | Method for providing a vaccine | |
DE410937C (en) | Process for the preparation of a measles protection serum | |
Zhdanov | The study of influenza | |
DE517204C (en) | Process for the manufacture of vaccines | |
EP0941118B1 (en) | Pharmaceutical antigen-antibody preparation | |
DE823120C (en) | Method of accelerating the setting of cementitious mixtures | |
DE102021001467A1 (en) | Inoculation of specific antigens from disease-causing agents in the form of drops or lyophilisate on the mucous membrane of the eyes or urogenital mucosa to generate immunity against these diseases | |
AT235470B (en) | Process for the deaggregation and purification of viruses | |
DE892362C (en) | Process for the recovery of avirulent pathogenic microbes in the manufacture of vaccines | |
DE2004869A1 (en) | Process for the preparation of an antiserum |